Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells

J Biol Chem. 2011 Jan 14;286(2):1025-36. doi: 10.1074/jbc.M110.158675. Epub 2010 Nov 8.

Abstract

Cytokines contribute to pancreatic islet inflammation, leading to impaired glucose homeostasis and diabetic diseases. A plethora of data shows that proinflammatory cytokines are produced in pancreatic islets by infiltrating mononuclear immune cells. Here, we show that pancreatic islet α cells and β cells express tumor necrosis factor-α (TNF-α) and other cytokines capable of promoting islet inflammation when exposed to interleukin-1β (IL-1β). Cytokine expression by β cells was dependent on calcineurin (CN)/nuclear factor of activated T cells (NFAT) and MAPK signaling. NFAT associated with the TNF-α promoter in response to stimuli and synergistically activated promoter activity with ATF2 and c-Jun. In contrast, the β-cell-specific transcriptional activator MafA could repress NFAT-mediated TNF-α gene expression whenever C/EBP-β was bound to the promoter. NFAT differentially regulated the TNF-α gene depending upon the expression and MAPK-dependent activation of interacting basic leucine zipper partners in β cells. Both p38 and JNK were required for induction of TNF-α mRNA and protein expression. Collectively, the data show that glucose and IL-1β can activate signaling pathways, which control induction and repression of cytokines in pancreatic endocrine cells. Thus, by these mechanisms, pancreatic β cells themselves may contribute to islet inflammation and their own immunological destruction in the pathogenesis of diabetes.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Basic-Leucine Zipper Transcription Factors / immunology
  • Basic-Leucine Zipper Transcription Factors / metabolism
  • CCAAT-Enhancer-Binding Protein-beta / immunology
  • CCAAT-Enhancer-Binding Protein-beta / metabolism
  • Calcineurin / immunology*
  • Calcineurin / metabolism
  • Cells, Cultured
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / metabolism
  • Diabetes Mellitus, Type 2 / immunology
  • Diabetes Mellitus, Type 2 / metabolism
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / immunology
  • Glucagon-Secreting Cells / immunology*
  • Glucagon-Secreting Cells / metabolism
  • Glucaric Acid / pharmacology
  • Insulin-Secreting Cells / immunology*
  • Insulin-Secreting Cells / metabolism
  • Interleukin-1beta / immunology
  • Interleukin-1beta / pharmacology
  • JNK Mitogen-Activated Protein Kinases / immunology
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Lectins, C-Type / immunology
  • Lectins, C-Type / metabolism
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / immunology*
  • Membrane Glycoproteins / immunology
  • Membrane Glycoproteins / metabolism
  • Mice
  • NFATC Transcription Factors / immunology*
  • NFATC Transcription Factors / metabolism
  • Promoter Regions, Genetic / immunology
  • Tumor Necrosis Factor-alpha / genetics*
  • Tumor Necrosis Factor-alpha / immunology
  • p38 Mitogen-Activated Protein Kinases / immunology
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Basic-Leucine Zipper Transcription Factors
  • CCAAT-Enhancer-Binding Protein-beta
  • Interleukin-1beta
  • Klrg1 protein, rat
  • Lectins, C-Type
  • Membrane Glycoproteins
  • NFATC Transcription Factors
  • Tumor Necrosis Factor-alpha
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Calcineurin
  • Glucaric Acid